Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Papers of the Week
Annotation


Klein JA, Longo-Guess CM, Rossmann MP, Seburn KL, Hurd RE, Frankel WN, Bronson RT, Ackerman SL. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature. 2002 Sep 26;419(6905):367-74. PubMed Abstract, View on AlzSWAN

  
Comments on Paper and Primary News
  Primary News: Oxidative Stress Triggers Neuronal Cell-Cycle Reentry

Comment by:  Paul Coleman, ARF Advisor
Submitted 26 September 2002  |  Permalink Posted 26 September 2002

This is a very thorough study that provides the Hq mutant mouse as the "first in vivo model for studying the role of oxidative stress on aberrant cell cycle re-entry and subsequent apoptosis." Thus, it links two classes of phenomena that have been described in the AD brain. In addition, the authors describe a selective effect on death of neurons in the cerebellum and retina. They convincingly demonstrate that other sets of neurons are resistant to the cell death they demonstrate in cerebellum and retina. The authors comment that "Similar to many gene products involved in neurodegenerative and other disorders, the expression pattern of AIF (the gene affected in their mutant) is much wider than the tissues phenotypically affected." They suggest that unaffected sets of neurons may be resistant to cell death by virtue of parallel mechanisms for coping with, in this case, peroxide production. This is a concept that has broad applicability beyond the class of challenge referred to here. It is notable that authors do not find differential selectivity to cell death in the mutant mice...  Read more

  Primary News: Oxidative Stress Triggers Neuronal Cell-Cycle Reentry

Comment by:  Inez Vincent, ARF Advisor
Submitted 26 September 2002  |  Permalink Posted 26 September 2002

I loved this paper.This work makes a compelling case for the involvement of oxidative stress in unscheduled cell cycle re-entry of postmitotic neurons, with consequent apoptosis. What is remarkable is the selective vulnerability of cerebellar and retinal neurons, despite of the fact that the AIF gene, in which the ecotropic provirus inserted, is expressed throughout brain. The Hq mutant mouse might therefore serve as a model not only for studying how oxidative damage leads to activation of the cell cycle in cerebellar neurons, but also for delineating the basis of the resistance to this death scheme of hippocampal and cerebral neurons for example. It is also curious that only neurons of the CNS seem to be affected in the Hq mouse – or was this the only tissue studied here? I did a search for more comprehensive phenotypic description of the Hq mouse, but found only one report about ichthyosis, a condition in which the skin becomes thickened, devoid of hair, and scaly. AIF is, apparently, expressed ubiquitously in normal tissues and in a variety of cancer cell lines. This Hq...  Read more

  Comment by:  George Perry (Disclosure)
Submitted 4 October 2002  |  Permalink Posted 4 October 2002
  I recommend this paper

Harlequin and Alzheimer Disease: Remarkable Parallels
If it takes years to die, it is not by an apoptotic mechanism. Klein and colleagues (2002) present an excellent model for this assertion and a couple of other phenomena that are present in Alzheimer disease (AD) and other neurodegenerative conditions. First, it shows how apoptotic death can be avoided in neurons that really do need to stick around (Raina et al., 2001). This phenomenon is remarkably similar to one we previously termed "abortosis" (Raina et al., 2001). Additionally, it provides a mechanism for how oxidative stress is proximal in the pathophysiology of AD (Nunomura et al., 2001) and by itself can lead to cell cycle re-entry in vulnerable neurons with subsequent arrest of the cell cycle program. Indeed, the combination of oxidative stress and cell cycle re-entry, in a "two-hit" manner, may be what bring forth the mature neurodegenerative phenotype in AD (Zhu et al., 2001). It will be exciting to see to what extent the Harlequin mutant mouse model parallels other aspects of neurodegenerative...  Read more
  Submit a Comment on this Paper
Cast your vote and/or make a comment on this paper. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend this paper

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
 
 

REAGENTS/MATERIAL:

Harlequin (Hq) mouse mutation was transfered to B6CBA mouse background. Genetic mapping on the X chromosome was performed by MIT/Whitehead Center for Genomics.

TUNEL assay (Roche) for apoptosis was performed on granule cells from Hq mutant and wildtype mice. Immunofluorescence studies on paraffin sections of cerebella and retinas of Hq mutant and wildtype mice used the following antibodies: anti-BrdU (1:50, Dako), PCNA (1:50, Santa Cruz), Cdc47 (1:50, NeoMarkers), 8-OHdG (1:1000, QED Bioscience), and rabbit polyclonal anti-caspase 3 ( 1:50, NeoMarkers), rabbit anti-activated caspase 3 (1:50, Cell Signaling) and rabbit anti-GFAP (1:50, Dako). For immunohistochemistry antibodies to calbindin-D28 (1:1500, Swant) were used with detection by DAB. Z-fixed (Anatch Ltd) frozen sections were stained with rabbit polyclonal anti-GABA receptor alpha 6 (1:50, Chemicon) and visualized with Cy-3 or FITC labeled donkey or goat secondary antibodies or mouse IgG1 or IgG2a goat secondary antibodies.

PCR was performed on DNA from Hq mutant mice, B6CBA littermate controls and CF1 mice. The splice junction of the viral insertion was determined by RT-PCR using a forward primer from exon 1 of aif and reverse primer from murine C type proviral envelope. 23 other mice strains were also genotyped for this insertion.

Western blot on brain extracts used goat anti-AIF (1:1000, Santa Cruz), anti-Crm1 (1:1000, Santa Cruz) or rabbit anti-human neuron-specific enolase (1:1000, Scytek) with HRP conjugated secondary antibodies and ECL for development.

Primary cultures of granule cells and cortical neurons from either day 7 or embryonic day 14.5 Hq and wildtype mice were obtained. Cell viability was assayed with propidium iodine and counter stained with Hoescht 33342. Statistical analysis was determined by one-tailed t test with a Bonferroni correction.

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad